GI Windows

Executive Summary

GI Windows is a privately held medical device company developing a novel magnetic anastomosis technology for gastrointestinal surgery. Their system creates an immediate, patent lumen via magnetic compression, offering potential advantages over traditional stapling in terms of healing, ease of use, and operating room efficiency. The technology has shown superior healing in preclinical studies and early clinical publications highlight its simplicity and procedural speed. However, the company remains in the pre-clinical stage with no disclosed funding or valuation, indicating early development trajectory. The platform's differentiated mechanism could address unmet needs in bariatric and general surgery if clinical validation proceeds successfully.

Upcoming Catalysts (preview)

• Q2 2026First-in-human clinical trial initiation40% success
• Q3 2026FDA pre-submission meeting or IDE approval50% success
• Q4 2026Series A funding round or strategic partnership30% success